ExecutiveOrdersEO

Policy → market

Market alerts

Not financial advice

Commercial cliffs from presidential documents — role pressure, mechanisms, and a curated issuer watchlist. Policy exposure mapping — not investment advice. Illustrative public companies are incomplete and not recommendations.

How this works
  1. Cliff vs glide — dates that change market access differ from multi-year programs.
  2. Role pressure — protective / adverse / mixed for supply-chain roles (not a stock tip).
  3. Named issuers — curated watchlist only.
  4. Price window — optional EOD chart around issue and cliff dates; coincidence, not causation.
Clear
  1. in 1dIssued Nov 28, 2025

    Launching the Genesis Mission

    Initial operating capability demonstration for at least one challenge

    ProtectiveAdverseMixedUncertain
    EO 143638/10Quiet signalProcurementSubsidy / incentiveLicensingSemiTechDefenseMineralsOil/gasPharmaUSCNEUJP
    ALBAlbemarleGOOGLAlphabetAAPLAppleAMATApplied MaterialsASMLASMLBABoeingAVGOBroadcomLNGCheniere Energy
  2. in 19dIssued Sep 17, 2025

    Presidential Determination on Major Drug Transit or Major Illicit Drug Producing Countries for Fiscal Year 2026

    Expected additional aggressive Mexican efforts against cartels

    AdverseMixed
    Det 2025-126/10Quiet signalTariffBan / prohibitionChemPharmaLogisticsTechUSCNMX
    AAPLAppleBASFYBASFDACDanaosFDXFedExLYBLyondellBasellNVSNovartisNVDANVIDIAPFEPfizer
  3. in 40dIssued Apr 9, 2026

    Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States

    Tariffs effective for other companies

    ProtectiveAdverseMixed
    Proc 110209/10TariffSubsidy / incentiveProcurementLicensingPharmaChemUSEUJPKR
    MMM3MALBAlbemarleBASFYBASFCTVACortevaDOWDowDDDuPontLLYEli LillyJNJJohnson & Johnson
  4. in 96dIssued Nov 28, 2025

    Launching the Genesis Mission

    First annual report to President on Platform status, outcomes, and partnerships

    ProtectiveAdverseMixedUncertain
    EO 143638/10Quiet signalProcurementSubsidy / incentiveLicensingSemiTechDefenseMineralsOil/gasPharmaUSCNEUJP
    ALBAlbemarleGOOGLAlphabetAAPLAppleAMATApplied MaterialsASMLASMLBABoeingAVGOBroadcomLNGCheniere Energy
  5. in 153dIssued Jan 14, 2026

    Continuation of the National Emergencies With Respect to the Southern Border of the United States and Cartels and Other Transnational Organizations

    Proclamation 10886 and EO 14157 one-year continuation expires unless renewed

    AdverseMixed
    Notice6/10Quiet signalTariffBan / prohibitionAutosAgChemOil/gasPharmaLogisticsUSCAMXCN
    MMM3MALBAlbemarleADMArcher Daniels MidlandBASFYBASFBGBungeCATCaterpillarLNGCheniere EnergyCVXChevron
  6. in 165dIssued Jan 14, 2026

    Continuation of the National Emergencies With Respect to the Southern Border of the United States and Cartels and Other Transnational Organizations

    EO 14193, EO 14194, and EO 14195 one-year continuation expires unless renewed

    AdverseMixed
    Notice6/10Quiet signalTariffBan / prohibitionAutosAgChemOil/gasPharmaLogisticsUSCAMXCN
    MMM3MALBAlbemarleADMArcher Daniels MidlandBASFYBASFBGBungeCATCaterpillarLNGCheniere EnergyCVXChevron
  7. in 225dIssued Mar 27, 2026

    Continuation of the National Emergency With Respect to Trade Practices That Contribute to Large and Persistent Annual United States Goods Trade Deficits

    Continued national emergency expires unless further extended

    ProtectiveAdverseMixed
    Notice6/10Quiet signalTariffBan / prohibitionLicensingMetalsAutosAgTechPharmaMineralsUSCNEUMX
    ALBAlbemarleAAAlcoaGOOGLAlphabetAAPLAppleADMArcher Daniels MidlandBGBungeCATCaterpillarCENXCentury Aluminum
  8. in 884dIssued Apr 9, 2026

    Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States

    Zero tariff rate expires for companies with MFN pricing agreements

    ProtectiveAdverseMixed
    Proc 110209/10TariffSubsidy / incentiveProcurementLicensingPharmaChemUSEUJPKR
    MMM3MALBAlbemarleBASFYBASFCTVACortevaDOWDowDDDuPontLLYEli LillyJNJJohnson & Johnson
  9. in 1321dIssued Apr 9, 2026

    Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients Into the United States

    20% onshoring rate increases to 100%

    ProtectiveAdverseMixed
    Proc 110209/10TariffSubsidy / incentiveProcurementLicensingPharmaChemUSEUJPKR
    MMM3MALBAlbemarleBASFYBASFCTVACortevaDOWDowDDDuPontLLYEli LillyJNJJohnson & Johnson
  10. Issued Mar 20, 2025

    Additional Rescissions of Harmful Executive Orders and Actions

    This executive order revokes 18 additional Biden-era executive actions, building on an earlier January 2025 order that r

    AdverseMixed
    EO 142367/10Quiet signalSubsidy / incentiveProcurementLicensingSolarMetalsOil/gasChemDefensePharmaUSCNEUKR
    MMM3MALBAlbemarleAAAlcoaBASFYBASFBABoeingCSIQCanadian SolarCENXCentury AluminumLNGCheniere Energy
Policy market alerts · Executive Orders